Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus

Grégoire Fauchier; Arnaud Bisson; Alexandre Bodin; Julien Herbert; Denis Angoulvant; P.H. Ducluzeau; Professor Gregory Lip; Laurent Fauchier

doi:10.1007/s00125-021-05551-y

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus

Alexandra Moss, Gerasimos Dimitropoulos, Derek Connolly, Professor Gregory Lip

Article2020

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Professor Gregory Lip, Allison Keshishian, Amiee Kang, Xiaoyan Li, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Anagha Nadkarni, Xianying Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Steven Deitelzweig

Article2019

Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus

Mia Vicki Fangel, Peter Brønnum Nielsen, Jette Kolding Kristensen, Torben Bjerregaard Larsen, Thure Filskov Overvad, Professor Gregory Lip, Martin Bach Jensen

Letter2022

New use for an old drug: Metformin and atrial fibrillation

Manlio Vinciguerra, Iván Olier, Sandra Ortega‐Martorell, Professor Gregory Lip

Article2016

Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation

Line Melgaard, Anders Gorst‐Rasmussen, Peter Søgaard, Lars Hvilsted Rasmussen, Professor Gregory Lip, Torben Bjerregaard Larsen